2017
$100M
from 10 investors over 10 rounds
Scribe Therapeutics raised undisclosed on May 17, 2023
Investors: Prevail Therapeutics
Scribe Therapeutics raised $100M on March 31, 2021
Investors: Wellington Management, RA Capital Management, L.P., T. Rowe Price, Andreessen Horowitz, Avoro Capital Advisors (formerly venBio Select Advisor), Perceptive Advisors, OrbiMed Advisors and Menlo Ventures
Scribe Therapeutics raised $20M on January 1, 2018
Investors: Andreessen Horowitz